The incidence and prevalence of inflammatory bowel diseases (IBD), Crohn's disease (CD)
and ulcerative colitis (UC), are lower in Asia than in the West. However, across Asia the …

The diagnosis of inflammatory bowel disease (IBD) is traditionally based on a combination
of clinical, endoscopic, histological, and radiological criteria. However, further testing is …

AIMS The aim of this study was to assess the diagnostic precision of anti Saccharomyces
cerevisiae (ASCA) and perinuclear antineutrophil cytoplasmic antibodies (pANCA) in …

OBJECTIVES: Although inflammatory bowel disease (IBD) has been reported worldwide,
most studies have focused on Caucasian populations. Our aim was to summarize the …

Background and Aims: Antibodies directed against oligomannose sequences α-1, 3 Man (α-
1, 2 Man α-1, 2 Man) n (n= 1 or 2), termed anti–Saccharomyces cerevisiae antibodies …

Inflammatory bowel disease (IBD) is increasing in many parts of the Asia‐Pacific region.
There is a need to improve the awareness of IBD and develop diagnostic and management …

METHODS One hundred forty-eight patients with IBD seen in a university gastroenterology
practice in Houston, Texas, between June 1999 and November 2003 were analyzed to …

The biomarkers are important in the Inflammatory Bowel Disease (IBD) to gain an objective
measurement of disease activity and severity, as well as prognostic indicator and outcome of …

Inflammatory bowel disease (IBD) was previously thought to be rare in Asia, but emerging
data indicate rising incidence and prevalence of IBD in the region. The Asia Pacific Working …

Background: Inflammatory bowel disease (IBD) is characterized by excessive immune
responses to altered intestinal microbiota in genetically susceptible individuals. The …